×
Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder PDF
$ 40.00
Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder PDF quantity
$ 40.00
×
Suicide Among Veterans Health Administration Patients With Bipolar Disorder: Evidence for Increased Risk Associated With Benzodiazepine Receipt PDF
$ 40.00
Suicide Among Veterans Health Administration Patients With Bipolar Disorder: Evidence for Increased Risk Associated With Benzodiazepine Receipt PDF quantity
$ 40.00
×
The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin PDF
$ 40.00
The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin PDF quantity
$ 40.00
×
Prophylactic Treatment With Escitalopram of Pegylated Interferon Alfa-2a-Induced Depression in Hepatitis C: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Prophylactic Treatment With Escitalopram of Pegylated Interferon Alfa-2a-Induced Depression in Hepatitis C: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Impact of Invalidation and Trust in Physicians on Health Outcomes in Fibromyalgia Patients PDF
$ 40.00
Impact of Invalidation and Trust in Physicians on Health Outcomes in Fibromyalgia Patients PDF quantity
$ 40.00
×
Attention-Deficit/Hyperactivity Disorder-Specific Quality of Life With Triple-Bead Mixed Amphetamine Salts (SPD465) in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Attention-Deficit/Hyperactivity Disorder-Specific Quality of Life With Triple-Bead Mixed Amphetamine Salts (SPD465) in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart